Have a personal or library account? Click to login
Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience Cover

Alectinib Treatment of ALK Positive Non Small Cell Lung Cancer Patients with Brain Metastases: Our Clinical Experience

PRILOZI
Volume 41 (2020): Issue 2 (September 2020)
By: Simonida Crvenkova  
Open Access
|Oct 2020

Authors

Simonida Crvenkova

simonidac@hotmail.com

University Clinic of Radiotherapy and Oncology, Faculty of Medicine, Skopje
DOI: https://doi.org/10.2478/prilozi-2020-0030 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 29 - 36
Published on: Oct 2, 2020
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
brain metastasis,
ALK+ NSCLC patients,
alectinib
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2020 Simonida Crvenkova, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 41 (2020): Issue 2 (September 2020)Next article